$SNX

TD SYNNEX CORP

CIK:0001177394|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Aug. 31, 2026	Aug. 31, 2025	Aug. 31, 2026	Aug. 31, 2025
Income Statement [Abstract]
Revenue	$ 21,558,406	$ 15,650,924	$ 58,294,417	$ 45,128,946
Cost of revenue	(20,132,992)	(14,521,071)	(54,277,396)	(41,954,714)
Gross profit	1,425,414	1,129,853	4,017,021	3,174,232
Selling, general and administrative expenses	(782,535)	(746,196)	(2,365,420)	(2,157,977)
Acquisition, integration and restructuring costs	(2,101)	(2,304)	(5,101)	(4,030)
Operating income	642,879	383,657	1,651,601	1,016,255
Interest expense and finance charges, net	(120,518)	(91,188)	(304,893)	(269,050)
Other income (expense), net	32,889	792	60,883	(983)
Income before income taxes	555,250	293,261	1,407,591	746,222
Provision for income taxes	(139,010)	(66,466)	(330,348)	(166,969)
Net income	$ 416,240	$ 226,795	$ 1,077,243	$ 579,253
Earnings per common share:
Basic (in USD per share)	$ 5.20	$ 2.76	$ 13.41	$ 6.95
Diluted (in USD per share)	$ 5.18	$ 2.74	$ 13.37	$ 6.92
Weighted-average common shares outstanding:
Basic (in shares)	79,213	81,561	79,570	82,593
Diluted (in shares)	79,413	81,901	79,777	82,928

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Aug. 31, 2026	Aug. 31, 2025
Cash flows from operating activities:
Net income	$ 1,077,243	$ 579,253
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	316,196	309,141
Share-based compensation	57,771	46,238
Gains on investments	(33,107)	0
Provision for common stock warrants	14,500
Provision for doubtful accounts	32,556	21,707
Other	354	3,715
Changes in operating assets and liabilities, net of acquisition of businesses:
Accounts receivable, net	(3,276,790)	(266,185)
Receivables from vendors, net	58,330	143,309
Inventories	(5,783,606)	(654,499)
Accounts payable	4,797,793	135,837
Other operating assets and liabilities	660,564	(247,190)
Net cash (used in) provided by operating activities	(2,078,194)	71,326
Cash flows from investing activities:
Purchases of property and equipment	(158,853)	(103,989)
Acquisition of businesses, net of cash acquired	(7,786)	(77,453)
Settlement of net investment hedges	(22,699)	(347)
Proceeds from sale of investments in equity securities	42,734	0
Other	235	5,032
Net cash used in investing activities	(146,369)	(176,757)
Cash flows from financing activities:
Dividends paid	(115,648)	(110,418)
Proceeds from reissuance of treasury stock	34,267	27,365
Repurchases of common stock	(292,368)	(423,129)
Repurchases of common stock for tax withholdings on equity awards	(7,471)	(9,340)
Net borrowings on revolving credit loans	1,638,536	345,099
Principal payments on long-term debt	(714,783)	(15,541)
Cash paid for debt issuance costs	(4,759)	0
Other	(9,597)	0
Net cash provided by (used in) financing activities	528,177	(185,964)
Effect of exchange rate changes on cash and cash equivalents	10,299	106,367
Net decrease in cash and cash equivalents	(1,686,087)	(185,028)
Cash and cash equivalents at beginning of period	2,435,389	1,059,378
Cash and cash equivalents at end of period	$ 749,302	$ 874,350

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Aug. 31, 2026	Nov. 30, 2025
Current assets:
Cash and cash equivalents	$ 749,302	$ 2,435,389
Accounts rceivable, net	14,953,804	11,707,581
Receivables from vendors, net	915,407	972,658
Inventories	15,291,597	9,504,340
Other current assets	983,781	669,470
Total current assets	32,893,891	25,289,438
Property and equipment, net	565,111	496,291
Goodwill	4,108,529	4,099,297
Intangible assets, net	3,559,885	3,774,952
Other assets, net	717,067	590,920
Total assets	41,844,483	34,250,898
Current liabilities:
Borrowings, current	1,926,400	1,018,321
Accounts payable	22,442,942	17,624,254
Other accrued liabilities	3,237,907	2,318,265
Total current liabilities	27,607,249	20,960,840
Long-term borrowings	3,595,337	3,592,130
Other long-term liabilities	524,345	447,981
Deferred tax liabilities	815,749	799,518
Total liabilities	32,542,680	25,800,469
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized, no shares issued or outstanding	0	0
Common stock, $0.001 par value, 200,000 shares authorized, 99,012 shares issued as of both August 31, 2026 and November 30, 2025	99	99
Additional paid-in capital	7,535,960	7,431,231
Treasury stock, 19,953 and 18,912 shares as of August 31, 2026 and November 30, 2025, respectively	(2,287,489)	(2,038,528)
Accumulated other comprehensive loss	(345,422)	(379,433)
Retained earnings	4,398,655	3,437,060
Total stockholders' equity	9,301,803	8,450,429
Total liabilities and equity	$ 41,844,483	$ 34,250,898